Life sciences

Unique, specialist and extensive expertise in providing legal services to the life sciences sector

We offer a full legal service to all our clients but recognise the particular importance of strong regulatory, commercial and intellectual property advice in the life sciences sector. The details of our lead partners in these areas are set out below.

In addition, our corporate team marries a unique mix of private sector corporate and corporate finance experience with an in depth knowledge of the life science and health sectors – particularly important for transactional work and where due diligence is required.

In addition to advising in relation to medical devices and pharmaceuticals, we have particular expertise in the fields of cell and gene therapy, reproductive and genetic technologies, and embryo research. See links below for more information on each.

We work with a wide range of public and private sector clients, including hospitals and clinics, private and publicly listed companies, universities, and charities.

Our services

  • Regulation
  • Intellectual property
  • Litigation
  • Commercial
  • Corporate
  • Data protection and information governance

Case studiesView all

  • Development of healthcare apps

    Advising on development of healthcare apps for patients, including advising NHS Northern England Strategic Clinical Networks on its Deciding Right app for making care decisions and NHS South East Commissioning Support Unit on its Health Help Now app to enable users to find the right service for their health needs.

    View Case study
  • Setting up new healthcare businesses

    Advising entrepreneurs on setting up new healthcare businesses including businesses delivering primary and community health services, medical services for foreign visitors to the UK and supplying locum doctors and nurses, including via online marketplace/gig economy models.

    View Case study

PeopleView all

EventsView all

Things you need to know about information governance to sell healthtech products into the NHS

The NHS encourages innovation in using technology in developing new and better ways of delivering care, managing health conditions and reducing hospital conditions. It is also a key marketplace for such products. NHS organisations also have large databases of patient related health data, which have the potential to be vital source of information for analysis and development of healthtech products. However, the NHS internal information governance rules place strict controls on the use of patient identifiable data including for cutting edge artificial intelligence products. Any healthtech product must be capable of operating within this framework in order to be a viable product to offer to NHS customers. This session will provide an introduction to the relevant rules and principles and sources of guidance and advice to technology companies seeking to develop products for this sector, including an overview of the role of anonymisation and psuedonymisation (including the use of controlled environments) and section 251 authorisations.

View Event

NewsView all